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ABSTRACT
The microbiological quality of 24 samples of oral pharmaceuticals comprising antacids, cough and paracetamol 
syrups purchased randomly from different drug stores operating in Abakaliki metropolis were assessed. They were 
analyzed by pour plate method. Their microbial load was determined using the viable cell count method. The 
resulting contaminating microorganisms were isolated and characterized by standard methods. The results revealed 
fungal and bacterial contaminations in 16 and 19 samples respectively. Contaminant bacteria include Bacillus spp., 
Staphylococcus spp., E.coli, Proteus spp, Klebsiella spp. and Pseudomonas spp. with Staphylococcus spp. being the 
most predominant bacterial contaminant, while fungi contaminants were basically Mucor and Aspergillus species. 
The pH values of the analyzed drugs ranged from 5 to 9. The variations in the stated pH of sampled products were
however, not justified in this work; thus queries the stated drug pH and why certain isolated organisms could grow 
on such pH outside their normal habitats’ pH. This study has shown therefore, that some oral pharmaceuticals sold 
in drug stores maybe heavily contaminated by varying microbial agents.
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INTRODUCTION 
At the beginning of the 21st century, microbial 
contamination of non-sterile products became one of 
the major reasons for product recalls and production 
shutdown (Jimenez, 2004). So far, microbial 
contamination of non-sterile pharmaceutical liquid 
products is rapidly becoming a matter of worldwide 
concern (Sykes, 1971), considering the fact that oral 
liquid pharmaceuticals are expected by their nature, 
to achieve maximum degree of sterility (Baird and 
Petrie, 1981). Unfortunately, Adeshina et al. (2009) 
submitted that oral liquid drug formulations such as 
aqueous solutions, suspensions, emulsions, and 
syrups used for children are at a greater risk of 
microbial contamination during consumption due to 
its sweetening-agent content, reconstitution methods, 
improper storage, and handling defects, which may 
ultimately contribute to secondary bacterial and 
fungal infections in these patients. This indicates that 
microbial contamination of routine drugs is becoming 
a public health challenge.
The United States Pharmacopoeia (USP) (1980) had 
suggested that liquid pharmaceuticals should not 
exceed 103 colony forming units per milliliter 
(cfu/ml) of bacteria, while yeast and mold should not 
exceed 102cfu/ml. Similarly, the National Agency for 
Food and Drug Administration and Control 
(NAFDAC) Hand Book (2000) had outlined the 
standard microbiological specifications for the 
certification of syrup oral suspensions. Thus, typical 
viable and fungal counts for bacterial and yeast cells 
must not exceed 1.0x103cfu/ml and 1.0x102cfu/ml for 
bacterial and fungal growth respectively.
Furthermore, Mohammad et al. (2012) had admitted 
in their work that the presence of certain micro-
organisms in non-sterile pharmaceutical products 
adversely affects the therapeutic activity of the 
product and even becomes detrimental to the health 
of the patient.
With the exception of preparations which are 
terminally sterilized, the micro-flora of final products 
may represent the contamination from the raw 
materials used in their formulation, the equipment 
used, the atmosphere, the operator of the process or 
from the final containers into which it was packed.
Indeed, as antacids, cough syrups and paracetamol 
syrups are the three widely used oral liquid 
formulations (amongst others) in Nigeria (Tukur et 
al., 2012), their microbiological safety is an 
important public health concern considering the fact 
that they are heavily commercialized and consumed 
by many people.
International Journal of Community Research http://www.anrescentpub.com
ISSN: 2315 – 6562
Emejuru et al., IJCR 2013; 2(3): 39-45 40
This study therefore, is designed to evaluate the 
microbial load in some selected oral liquid 
pharmaceuticals in comparison with the permissible 
levels of contaminants officially allowed for such 
commercially available products.
MATERIALS AND METHODS
Study area: This study was carried out in Abakaliki 
Metropolis, the Capital City of Ebonyi State, situated 
in the Southeastern geopolitical zone of Nigeria.
Geographically, Abakaliki is located between 
601511811N and 80051 5511E. The state owned 
University (Ebonyi State University), the Federal 
Teaching Hospital, and other governmental/non-
governmental institutions are amongst the institutions 
located in Abakiliki.
According to Nigeria Population Commission (NPC)
census (2006), Abakaliki has a population of about 
149,683 with the larger population being civil 
servants. The state is notable for her agricultural 
prowess and renowned for the production of salt; 
hence the state acronym “salt of the nation”.
Sampling technique: Twenty-four (24) properly 
sealed and packed oral liquid drugs of antacids, 
cough syrups, and paracetamol syrups (2 samples 
each of 4 different brands) produced by NAFDAC 
approved manufacturing pharmaceutical companies, 
were randomly purchased from various operating 
drug stores in Abakaliki metropolis. They were 
checked for their batch numbers, production date, 
expiry dates and certified intact.
The samples were then labeled for the purpose of this 
work and stored in a cool and dry laboratory shelf at 
room temperature (24-25oC) as recommended by the 
manufacture.
LABORATORY ANALYSIS 
Preliminary assessment (Macroscopy): The 
NAFDAC number, colour, and taste of the samples 
were assessed. Drug pH and 
preservatives/constituents were also noted (Table 1).
Enumeration of microbial contaminants 
(Microscopy): Inoculation by pour plate method was 
carried out after 1 in 100 serial dilutions of the 
various samples were carried out. 1ml of each of the 
diluted sample was then aseptically aspirated into 
each media (Nutrient Agar, MacConkey Agar, and 
Sabouraud Dextrose Agar) respectively. The media 
was poured aseptically into the sterile Petri dishes for 
each media at 40-45oC and then swirled following 
which they were allowed to solidify for incubation at
the appropriate temperature (Nutrient and 
MacConkey Agar plates at 370C for 24-48 hours;
while Sabouraud Dextrose Agar plates at 25±20C for 
3-5days) for the enumeration of total viable and 
fungal counts respectively. 
Typical colonies of microbial growth on plates were 
counted at the end of incubation and the total number 
of counts were multiplied by 10-2 (dilution factor) to 
get the total viable count for all samples as described 
by Fawole and Oso (1988) and Ochei and Kolhatkar 
(2008).
The results obtained were after wards, compared with 
the standard microbiological specifications for 
certification of syrups and with the microbiological 
permissible levels as judged by USP (1980) and 
NAFDAC Handbook (2000).
Characterization of isolates: The bacterial isolates 
were identified by Gram staining techniques and 
other biochemical tests (catalase, coagulase, oxidase, 
indole, methyl red and motility test by hanging drop 
method) as described by Fawole and Oso (1988)
Cheesbrough (2000), Baker et al. (1998) while fungal 
isolation was based on growth rate and colonial 
morphology as described by Ochei and Kolhatkar
(2008).
Sterilizations of glassware’s and materials used for 
this research work were achieved by the use of direct 
heat and hot air oven as described by Isu and 
Onyeagba (2002).
RESULTS
Results from the microbiological analysis showed 
that out of the 24 samples of different brands of three 
oral pharmaceuticals (antacid, cough syrup and 
paracetamol syrup), 19 (79.17%) yielded growths 
while 5 (20.83%) yielded no growths (see tables 2 
and figure 1).
Also, a number of bacteria organisms were isolated 
from the various samples as shown in tables 3 below.
For fungal isolates, 16 (66.67%) out of the 24 sample 
analyzed yielded growths while the rest 8 (33.33%) 
yielded no growth as shown in tables 4 below. Most 
recognizable fungal isolates were of Mucor and 
Aspergillus species. The growth pattern (in 
percentages) was graphically illustrated in figure 2
below. 
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Table 1: Preliminary Assessment of the samples
Sample/brand NAFDAC 
No
pH Colour Taste Constituents/Preservatives 
used
Antacids
Emtricil 04-1455 9.0 White Sour AMS, MT, MC, SB, S
Gestid 04-0480 8.0 Pink Sour Dried AH Gel, MH, 
Activated PMS.
Mist mag 04-3165 9.0 White Sour MT, Light MC.
Stopacid 04-4841 8.0 White Sour MH, Dried AH gel,
Cough syrups
D-koff 04-2751 5.0 Amber Sweet DPH, BH, AC, SC, 
Methanol
Emzolyn 04-0266 5.0 Amber Sweet DPH, AC, SC, Methanol
Benylin 04-0887 5.0 Pink Sweet DPH, SC, PH Eur
Codrux A4-7704 5.0 Pink Sweet DPH, AC Methanol SC.
Paracetamol syrups
Albemol A4-7709 5.0 Pink Sweet Paracetamal BP
Acepol A4-0704 5.0 Pink Sweet Paracetamal BP
Emcap 04-7339 5.0 White Sweet Paracetamal BP
MB 5 04-0247 5.0 Pink Sweet Paracetamal BP
KEY: AMS - Aluminum Magnesium Silicate; MT - Magnesium Trisilicate,; MC - Methicone.; MH - Magnesium 
Hydroxide; Dried AH Gel - Dried Aluminum Hydroxide Gel; Activated PMS - Activated 
Polymethylsiloxane  ; DPH- Diphenhydramine Hydrogen chloride; BH- Bromohexine Hydrogen chloride; 
AC - Ammonium Chloride; SC- Sodium Citrate










Emtricil 2 2 - 100
Gestid 2 - 2 0
Mist mag 2 2 - 100
Stopacid 2 1 1 50
Cough syrups
D-koff 2 2 - 100
Emzolyn 2 2 - 100
Benylin 2 1 1 50
Codrux 2 2 - 100
Paracetamol syrups
Albemol 2 1 1 50
Acepol 2 2 - 100
Emcap 2 2 - 100
MB5 2 2 - 100
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Table 3: Bacteria’s isolated from each of the samples




Emtricil 2 Staph. spp.
Mist Mag 2 E. coli, Klebsiella spp., Proteus spp. 
Stopacid 1 Klebsiella spp., Proteus spp., Bacillus spp., 
E.coli.
Cough syrups
D- koff 2 Staph spp
Emzolyn 2 Pseudomonas spp.,E.coli, Proteus spp. 
Benylin 1 Staph. spp.
Codrux 2 E.coli. 
Paracetamol syrups
Albemol 1 Staph. Spp.
Acepol 2 Staph. spp., Pseudomonas spp. 
Emcap 2 Proteus spp. 
MB 5 2 Staph spp.
Table 4: Fungal Growth Analysis on each of the Samples and their Percentages









Emtricil 2 2 - 100
Gestid 2 1 1 50
Mist Mag 2 2 - 100
Stopacid 2 1 1 50
Cough syrups
D-koff 2 2 - 100
Emzolyn 2 - 2 100
Benylin 2 1 1 50
Codrux 2 1 1 50
Paracetamol syrups
Albemol 2 2 - 100
Acepol 2 1 1 50
Emcap 2 2 - 100
MB 5 2 1 1 50
DISCUSSION
This study aligns with the argument by Sheikh et al., 
(1988) that sterility is not a requirement in the official 
compendia for oral pharmaceutical dosage forms. It 
also implies that contamination may occur during 
manufacturing, packaging, and/or handling by the 
consumer (Baird, 2004; Ibezim et al., 2002). Of 
course, this raises concern since some drug forms,
even though stored in favorable environment, can 
serve as substrates for micro-organisms (Sapra et al., 
2012). More so, variations in the stated pH of 
sampled products were not highly justified, thereby 
querying the authenticity of such stated (but 
questionable) pH; contrary to established normal 
habitat’s pH. Indeed, the ability of certain organisms
(as seen in this study) to grow at such stated pH, 
makes it more worrisome. This implies that certain 
drug constituents (in addition to their normal roles), 
are microbial growth enhancers. Interestingly, Baird 
and Petrie (1981) states that liquid antacids often 
contain ingredients of high basic pH, which readily 
support the growth of a variety of micro-organisms,
when appropriate precautions are not taken.
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Fig I: Pie- chart representation of percentage bacterial growth and no growth
NB: Summary: No. of growths = 19(79.17%) No. of no growths = 5(20.85%)
Fig 2: Pie- chart representation of percentage fungal growth and no growth
NB. Summary: No of growths = 16 (66.67%) No of no growths = 8(33.33%)
According to NAFDAC Handbook (2000), bacterial 
count should not exceed 1000 cfu/ml, but 
unfortunately, out of the 19 samples with growth, 8 
(42.11%) samples exceeded this rule in Nutrient 
Agar, while 11 (57.89%) samples exceeded it in 
MacConkey Agar. 
Given the heavy contamination observed in this 
study, predominantly Staphylococcus aureus, it is a 
worrisome trend as such organism secretes toxins that 
contribute to serious gastrointestinal distress (Denyer, 
1990). In addition, the presence of Escherichia coli is 
a good indicator of faecal contamination probably 
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from the water used. This might be responsible for 
reported cases of infant diarrhea in some parts of 
Nigeria (Antai and Anozie, 1987).
Similarly, NAFDAC Handbook (2000) stipulates that 
fungi count must not exceed 1.0x102cfc/ml, but the 
results on fungi count far exceeded this value in all 
the 16 samples with fungi growth. Given the high
toxin producing nature of some Aspergillus spp,
especially Aspergillus flavus, serious problems could 
result in man due to its high aflatoxin production- a 
known carcinogenic agent (Fortnum, 1986; Payne 
and Brown, 1998; Abbas et al., 2004).
Over all, the findings of this study imply that water 
supply, raw materials and lack of personal hygiene 
have remained the major sources of contamination in 
pharmaceuticals. Also implicated, are the high levels 
of sweetening and preservative agents (Mahboob et 
al., 2004). In fact, sweeteners of high sugar category
in drugs, have been known to enhance microbial 
growth (Mahboob et al., 2004); hence the need for 
caution.
It is our recommendation therefore, that health care 
providers should monitor this trend, while NAFDAC 
is encouraged to tighten regulations in this regard.
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